DreaMed Diabetes
Founded Year
2014Stage
Seed - II | AliveTotal Raised
$8.7MLast Raised
$3.3M | 7 yrs agoAbout DreaMed Diabetes
DreaMed Diabetes develops health solutions and decision support tools using algorithms for the optimization of intensive insulin therapy for the benefit of people with Type 1 and Type 2 diabetes. The company's first product, GlucoSitter, was developed for closed-loop insulin therapy and was licensed to Medtronic. The company's latest product, Advisor, its decision support technology platform for determining the optimal patient-specific insulin treatment plans leading to balanced glucose levels in people with diabetes. The system uses event-driven machine learning and logic technology in order to process multiple personalized parameters, such as insulin delivery data, glucose readings, meal data and more into an informed and optimized insulin dosing treatment plan.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Research containing DreaMed Diabetes
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned DreaMed Diabetes in 1 CB Insights research brief, most recently on Oct 28, 2022.
Expert Collections containing DreaMed Diabetes
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
DreaMed Diabetes is included in 2 Expert Collections, including Artificial Intelligence.
Artificial Intelligence
10,944 items
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
Digital Health
10,567 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
DreaMed Diabetes Patents
DreaMed Diabetes has filed 4 patents.
The 3 most popular patent topics include:
- Diabetes
- Insulin therapies
- Blood tests
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/21/2015 | 11/29/2016 | Diabetes, Insulin therapies, Blood tests, Implants (medicine), ARM architecture | Grant |
Application Date | 1/21/2015 |
|---|---|
Grant Date | 11/29/2016 |
Title | |
Related Topics | Diabetes, Insulin therapies, Blood tests, Implants (medicine), ARM architecture |
Status | Grant |
Latest DreaMed Diabetes News
Mar 20, 2023
DUBLIN--(BUSINESS WIRE)--The "AI in Diabetes Management: Global Market Outlook" report has been added to ResearchAndMarkets.com's offering. In this report, the market has been segmented based on product type, technique and geographic region. The report provides an overview of the global market for AI in diabetes management and analyzes market trends. Using 2021 as the base year, the report provides estimated market data and revenue projections for the forecast period of 2022-2027. Market values
DreaMed Diabetes Frequently Asked Questions (FAQ)
When was DreaMed Diabetes founded?
DreaMed Diabetes was founded in 2014.
Where is DreaMed Diabetes's headquarters?
DreaMed Diabetes's headquarters is located at 3 Shimshon St, Petah Tikva.
What is DreaMed Diabetes's latest funding round?
DreaMed Diabetes's latest funding round is Seed - II.
How much did DreaMed Diabetes raise?
DreaMed Diabetes raised a total of $8.7M.
Who are the investors of DreaMed Diabetes?
Investors of DreaMed Diabetes include Roman Abramovich, The Leona M. and Harry B. Helmsley Charitable Trust and Medtronic.
Who are DreaMed Diabetes's competitors?
Competitors of DreaMed Diabetes include GlucoGear and 1 more.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Compare DreaMed Diabetes to Competitors
Tidepool operates an open platform to help people reduce the burden of managing type 1 diabetes. Its platform makes diabetes data more accessible, stored, and managed in a cloud-based platform, made available for providers and patients to look at, and presented across all devices. The company was founded in 2012 and is based in Palo Alto, California.
One Drop operates as a diabetes management platform. It allows users to track their glucose levels using a variety of devices, including blood glucose meters, continuous glucose monitors (CGMs), and insulin pumps. It also offers a mobile application that provides personalized coaching to help users achieve their health goals. The company was founded in 2014 and is based in New York, New York.
Glooko's universal diabetes software products provide insights to improve outcomes for people with diabetes and their care teams. Glooko's systems synchronize data from more than 190 diabetes devices and activity trackers, and they deliver integrated, timely and useful patient data, including glucose levels, blood pressure, weight, and food, insulin and medication intake.
Klivo operates as a chronic patient care coordination platform. It tracks, engages, and educates patients to incentivize better habits, improve overall health, and reduce the burden on the healthcare system. It fills gaps in the healthcare system related to chronic, non-communicable diseases. The company was founded in 2019 and is based in Sao Paulo, Brazil.
Sweetch Health is a hyper-personalized engagement platform to improve clinical outcomes for people with chronic conditions. The company's platform allows individuals to achieve health goals with hyper-personalized recommendations in the right time, tone, and real-world context. It was founded in 2013 and is based in Ramat Gan, Israel.
Beta Bionics is a biotechnology company that provides a bionic pancreas device for glucose metabolism to the diabetes community. Its product iLet is an automated insulin delivery system that undertakes decisions regarding diabetes management on behalf of the patients. The company was founded in 2016 and is based in Irvine, California.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
